Jane Wasman - Net Worth and Insider Trading
Jane Wasman Net Worth
The estimated net worth of Jane Wasman is at least $410,109 dollars as of 2026-09-10. Jane Wasman is the Director of SELLAS Life Sciences Group Inc and owns about 30,400 shares of SELLAS Life Sciences Group Inc (SLS) stock worth over $410,096. Jane Wasman is also the President, Intl and GC of Acorda Therapeutics Inc and owns about 979 shares of Acorda Therapeutics Inc (ACORQ) stock worth over $13. Details can be seen in Jane Wasman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jane Wasman has not made any transactions after 2025-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jane Wasman
Jane Wasman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jane Wasman owns 4 companies in total, including Rigel Pharmaceuticals Inc (RIGL) , SELLAS Life Sciences Group Inc (SLS) , and Acorda Therapeutics Inc (ACORQ) among others .
Click here to see the complete history of Jane Wasman’s form 4 insider trades.
Insider Ownership Summary of Jane Wasman
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | 2022-05-20 | director |
| SLS | SELLAS Life Sciences Group Inc | 2025-05-30 | director |
| ACORQ | Acorda Therapeutics Inc | 2019-12-02 | Exec V Pres & Gen Cnsl & Sec |
 | | 2020-11-12 | director |
Jane Wasman Latest Holdings Summary
Jane Wasman currently owns a total of 2 stocks. Among these stocks, Jane Wasman owns 30,400 shares of SELLAS Life Sciences Group Inc (SLS) as of May 30, 2025, with a value of $410,096 and a weighting of 100%. Jane Wasman also owns 979 shares of Acorda Therapeutics Inc (ACORQ) as of December 2, 2019, with a value of $13 and a weighting of 0%.
Latest Holdings of Jane Wasman
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLS | SELLAS Life Sciences Group Inc | 2025-05-30 | 30,400 | 13.49 | 410,096 |
| ACORQ | Acorda Therapeutics Inc | 2019-12-02 | 979 | 0.01 | 13 |
Holding Weightings of Jane Wasman
Jane Wasman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jane Wasman has made a total of 1 transactions in SELLAS Life Sciences Group Inc (SLS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in SELLAS Life Sciences Group Inc is the acquisition of 20,000 shares on May 30, 2025, which cost Jane Wasman around $33,800.
According to the SEC Form 4 filings, Jane Wasman has made a total of 0 transactions in Acorda Therapeutics Inc (ACORQ) over the past 5 years. The most-recent trade in Acorda Therapeutics Inc is the sale of 19 shares on December 2, 2019, which brought Jane Wasman around $3,563.
Insider Trading History of Jane Wasman
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Jane Wasman Trading Performance
GuruFocus tracks the stock performance after each of Jane Wasman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jane Wasman is 12.28%. GuruFocus also compares Jane Wasman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jane Wasman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jane Wasman's insider trading performs compared to the benchmark.
Performance of Jane Wasman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 28.07 | | | | | |
| Relative Return to S&P 500(%) | 23.11 | | | | | |
Jane Wasman Ownership Network
Ownership Network List of Jane Wasman
Ownership Network Relation of Jane Wasman
Jane Wasman Owned Company Details
What does Rigel Pharmaceuticals Inc do?
Who are the key executives at Rigel Pharmaceuticals Inc?
Jane Wasman is the director of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Commercial Officer David A Santos , EVP & GC & CCO & Corp Sec Raymond J. Furey , and EVP & Chief Financial Officer Dean L Schorno .
Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary
Over the past 18 months, Jane Wasman made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 5,000 shares made by Kamil Ali-jackson , and a net sale of 4,000 shares made by Walter H Moos .
In summary, during the past 3 months, insiders sold 2,500 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 9,000 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,000 shares.
Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rigel Pharmaceuticals Inc Insider Transactions
Jane Wasman Mailing Address
Above is the net worth, insider trading, and ownership report for Jane Wasman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jane Wasman's mailing address is: Ardsley Ny 10502.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
